KOSDAQ · Healthcare · ₩280B
₩21,900+6.31%
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
6/'26
3/'26 vs prev quarter
Short Volume 6.3% · as of 26.10.27
Among 98 제약 peers
Quarterly Revenue Growth
“사업을 다시 묶는 방향은 선명하지만 이익 회복 확인이 먼저예요.”
In the company's words · 2026 2분기 filing